Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zenas BioPharma (ZBIO) Non-cash Items (2023 - 2025)

Zenas BioPharma has reported Non-cash Items over the past 3 years, most recently at $83.7 million for Q4 2025.

  • Quarterly results put Non-cash Items at $83.7 million for Q4 2025, up 3878.14% from a year ago — trailing twelve months through Dec 2025 was $83.7 million (up 3878.14% YoY), and the annual figure for FY2025 was $83.7 million, up 3878.14%.
  • Non-cash Items for Q4 2025 was $83.7 million at Zenas BioPharma, down from $98.1 million in the prior quarter.
  • Over the last five years, Non-cash Items for ZBIO hit a ceiling of $98.1 million in Q3 2025 and a floor of $1.0 million in Q3 2024.
  • Median Non-cash Items over the past 3 years was $3.5 million (2025), compared with a mean of $28.3 million.
  • Biggest five-year swings in Non-cash Items: crashed 73.97% in 2024 and later surged 9546.2% in 2025.
  • Zenas BioPharma's Non-cash Items stood at $8.1 million in 2023, then crashed by 73.97% to $2.1 million in 2024, then soared by 3878.14% to $83.7 million in 2025.
  • The last three reported values for Non-cash Items were $83.7 million (Q4 2025), $98.1 million (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.